Profile

Stefan Charles Grant, M.D., J.D.Wake Forest School of Medicine

Doctor Rating

No Rating Available
Why No Ratings?

Stefan Charles Grant, M.D., J.D.

Associate Professor,

Clinical Interests

Thoracic Cancer

Contact Information

Returning Patient Appointments: 336-713-5440
Department: 336-713-5172

Insurance Accepted »

Education & Training

  • M.B.,B.Ch., University of the Witwatersrand-South Africa, 1981
  • J.D., Fordham University, 1998
  • Residency, Internal Medicine, ICR Royal Marsden Cancer Hosp, 1983
  • Residency, Internal Medicine, Albert Einstein Med Ctr, 1988
  • Fellowship, Hematology And Oncology, Memorial Sloan Kettering Cance, 1992

Board Certifications

  • American Board of Internal Medicine, Hematology
  • American Board of Internal Medicine, Internal Medicine
  • American Board of Internal Medicine, Medical Oncology

NPI Number

  • 1407979032
Stefan Charles Grant, M.D., J.D.

Doctor Rating

No Rating Available
Why No Ratings?

Stefan Charles Grant, M.D., J.D.

Associate Professor, Hematology & Oncology

Research Interests

Lung Neoplasms; Adenocarcinoma; Genotype; Carcinoma, Non-Small-Cell Lung; Carcinoma, Small Cell
More »

Contact Information

Academic: 336-716-4464 | Department: 336-713-5172

Recent Publications

Identification of independent negative prognostic factors in stage IV non-small cell lung cancer [abstract]. Badawy AA, Bae S, Grant SC.. J Clin Oncol. 2015;33(15 Suppl):e19133.

An evaluation of systemic therapy beyond second-line therapy in patients with stage IV non-small cell lung cancer [abstract]. Badawy AA, Bae S, Grant SC.. J Clin Oncol. 2015;33(15 Suppl):e19129.

Phase I/IIa study of sequential chemotherapy regimen of bendamustine/irinotecan followed by etoposide/carboplatin in untreated patients with extensive disease small cell lung cancer (EDSCLC). Allendorf DJ, Bordoni RE, Grant SC, Saleh MN, Reddy VB, Jerome ML, Dixon PM, Miley DK, Singh KP, Robert F.. Cancer Chemother Pharmacol. 2015;76(5):949-955.

Treatment beyond second line chemotherapy outside of a clinical trial is appropriate for selected NSCLC patients [abstract]. Badawy AA, Bae S, Grant SC.. J Thorac Oncol. 2015;10(9 Suppl 2):S654.

An evaluation of chemotherapy regimens in an unselected population of NSCLC patients [abstract]. Badawy AA, Bae S, Grant SC.. J Thorac Oncol. 2015;10(9 Suppl 2):S317.

Checkpoint kinase (CHK) 1/2 inhibitor LY2606368 in a phase I dose-expansion study in patients with squamous cell carcinoma of the head and neck [abstract]. Bendell J, Grant S, Janku F, Infante J, William WN, Bauer TM, Piha-Paul S, Martinez R, Wijayawardana S, Lin J, Golden L, Lin AB, Hong D.. Cancer Res. 2015;75(15 Suppl):CT240.

Making the diagnosis of cardiac tamponade in lung cancer patients [abstract]. Ghatalia P, Wang C, Grant SC.. J Thorac Oncol. 2015;10(9 Suppl 2):S537.

Robotic thoracic surgery for elderly patients with non-small cell lung cancer [abstract]. Hughes RT, Dipasquale VM, Grant SC, Lally BE, Petty WJ, Proto A, Wudel LJ.. J Thorac Oncol. 2015;10(9 Suppl 2):S561.

Nodal staging via robotic-assisted thoracic surgery for clinical stage I non-small cell lung cancer [abstract]. Dipasquale VM, Hughes RT, Grant S, Lally BE, Petty WJ, Proto A, Wudel LJ.. J Thorac Oncol. 2015;10(9 Suppl 2):S333.

All Publications

For a listing of recent publications, refer to PubMed, a service provided by the National Library of Medicine.

For a list of earlier publications, visit the Carpenter Library Publication Search.

Associate Professor, Hematology & Oncology

Clinical Interests

Thoracic Cancer
Stefan Charles Grant, M.D., J.D.

Stefan Charles Grant, M.D., J.D.

Associate Professor, Hematology & Oncology

CP concern for questions/worries
4.7
CP efforts to include in decisions
4.6
CP explanations of prob/condition
4.6
CP spoke using clear language
4.5
Friendliness/courtesy of CP
4.7
Likelihood of recommending CP
4.6
Patients' confidence in CP
4.7
Time CP spent with patient
4.4
Wait time at clinic
3.2



Patient Comments

Comments are taken from the Care Provider section of the Press Ganey Patient Satisfaction Survey. Comments are posted exactly as they are written. Comments are added weekly. To protect patient privacy and confidentiality, patient names are not included.

9/19/2016

*Dr. Grant is an excellent and compassionate physician.

8/26/2016

good

8/16/2016

he was tobthe point and really cared

8/2/2016

*Dr. Grant was great! Our three hour trip was worth it.

Quick Reference

Request an Appointment
New Patients

336-716-WAKE
888-716-WAKE

Existing patients may contact the clinic directly.
Find a Doctor Ways to Give
Comprehensive Cancer Centers National Designation is RenewedMagnet Hospital RecognitionConsumer Choice2015 Best DoctorsJoint Commission Report

Disclaimer: The information on this website is for general informational purposes only and SHOULD NOT be relied upon as a substitute for sound professional medical advice, evaluation or care from your physician or other qualified health care provider.

© Wake Forest Baptist Medical Center, Medical Center Boulevard, Winston-Salem, NC 27157. All Rights Reserved.